MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,856,376 | -58.3% | 6,186,123 | +8.1% | 0.00% | – |
| Q2 2023 | $18,833,997 | -1.2% | 5,724,619 | +23.4% | 0.00% | – |
| Q1 2023 | $19,064,202 | -26.9% | 4,638,492 | +4.3% | 0.00% | -100.0% |
| Q4 2022 | $26,071,374 | -11.9% | 4,449,040 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $29,596,000 | +35.3% | 4,377,999 | -7.5% | 0.00% | 0.0% |
| Q2 2022 | $21,871,000 | +59.6% | 4,733,731 | +37.8% | 0.00% | – |
| Q1 2022 | $13,707,000 | -38.9% | 3,435,270 | -4.8% | 0.00% | -100.0% |
| Q4 2021 | $22,438,000 | -35.4% | 3,607,431 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $34,718,000 | -19.6% | 3,681,594 | +15.7% | 0.00% | 0.0% |
| Q2 2021 | $43,206,000 | -14.3% | 3,181,585 | +2.1% | 0.00% | 0.0% |
| Q1 2021 | $50,438,000 | -38.2% | 3,117,369 | +1.6% | 0.00% | -50.0% |
| Q4 2020 | $81,654,000 | +54.4% | 3,068,518 | +8.0% | 0.00% | 0.0% |
| Q3 2020 | $52,894,000 | -21.1% | 2,840,701 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $67,028,000 | +507.7% | 2,864,463 | +51.4% | 0.00% | – |
| Q1 2020 | $11,030,000 | +3.1% | 1,892,028 | +1.3% | 0.00% | – |
| Q4 2019 | $10,699,000 | +261.8% | 1,867,264 | -0.2% | 0.00% | – |
| Q3 2019 | $2,957,000 | -61.6% | 1,871,471 | -1.7% | 0.00% | – |
| Q2 2019 | $7,709,000 | -2.3% | 1,903,502 | +26.9% | 0.00% | – |
| Q1 2019 | $7,892,000 | +625.4% | 1,500,491 | +462.6% | 0.00% | – |
| Q4 2018 | $1,088,000 | -81.9% | 266,684 | -55.6% | 0.00% | – |
| Q3 2018 | $6,011,000 | -24.7% | 601,101 | +34.4% | 0.00% | – |
| Q2 2018 | $7,987,000 | +20.1% | 447,178 | +6.0% | 0.00% | – |
| Q1 2018 | $6,651,000 | +123.3% | 421,698 | +132.5% | 0.00% | – |
| Q4 2017 | $2,979,000 | +8.8% | 181,337 | +14.5% | 0.00% | – |
| Q3 2017 | $2,739,000 | +161.4% | 158,437 | +111.2% | 0.00% | – |
| Q2 2017 | $1,048,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |